Category Archives: Quarterly Results

Watanabe & Brothers’ Investment today announced its financial results for fiscal 2022 third quarter ended December 31, 2022.  In this regard, gross assets of our “Orphan Fund” was decreased by as much as 44% with respect to 2021 Q3. It was possibly due to rising long-term interest rates in the U.S. treasury bonds markets.  WeContinue reading “Watanabe & Brothers’ Investment announced 2022 Q3 Financial Results “

We are very pleased to inform that Watanabe & Brother’s Investment announced 2022 Q2 financial results on October 6, 2022.  In this regard, our fund suffered a loss of 15% with respect to 2021 Q1 (JPY, YoY). We believe that it was due to further rising long-term interest rates as well as rising inflation ratesContinue reading “Watanabe & Brothers’ Investment announced 2022 Q2 Financial Results”

We are very pleased to inform you that Watanabe & Brothers’ Investment announced 2022 Q1 financial results on July 4, 2022. In 2022 Q1, our fund suffered from a loss of 19% with respect to 2021 Q1. We believe that it was due to rising industrial prices as well as rising interest rates in theContinue reading “Watanabe & Brothers’ Investment announced 2022 Q1 Financial Results”

We are very pleased to inform you that Watanabe & Brothers’ Investment announced 2021 Q3 financial results on January 3rd, 2022.   In this regard, our fund underwent 23% growth (YoY) with respect to 2020 Q3. In 2021 Q3, we were suffering from the higher volatility of stock market due to the higher inflation rateContinue reading “Watanabe & Brothers’ Investment announced 2021 Q3 Financial Results on January 3rd, 2022”

We are very pleased to inform you that Watanabe & Brothers’ Investment announced 2021 Q2 financial results. In this regard, our fund underwent 30% growth (YoY) with respect to 2020 Q2.  In 2021 Q2, our fund was continuously suffering from its lower growth rate due to the increased volatility of stock market and increased inflationContinue reading “Watanabe & Brothers’ Investment announced 2021 Q2 Financial Results on October 2nd, 2021”

We are very pleased to inform you that Watanabe & Brothers’ Investment announced 2021 Q1 financial results. In this regard, our fund underwent 53% growth (YoY) with respect to 2020 Q1.  In 2021 Q1, our fund was suffering from its lower growth rate. It was due to a surge in nominal interest rate since thisContinue reading “Watanabe & Brothers’ Investment announced 2021 Q1 Financial Results on July 3rd, 2021”

We are very pleased to inform you that Watanabe & Brothers’ Investment announced 2020 Q3 Earning Results on January 1st, 2021.  In this regard, our fund underwent 49% growth during the quarter (YoY). Despite of the forecast disclosed on August 16th, 2020, we expect 85 to 95% growth (TTM) of our fund during FY2020.  WeContinue reading “Watanabe & Brothers’ Investment announced 3rd Quarter Earning Results on January 1st, 2021”

We are very pleased to inform you that Watanabe & Brothers’ Investment announced the quarterly results of 2020 2nd Quarter on October 1st, 2020.  In the 2nd Quarter, our fund underwent 46% growth despite of the temporal decline of the US listed stocks in this September.  In this regard, we purchased shares of Teladoc HealthContinue reading “Watanabe & Brothers’ Investment announced the 2nd Quarter Earning Results on October 1st, 2020”

We, Watanabe & Brothers’ Investment, are very pleased to release the Quarterly Results of the 2020 1st quarter of our “Orphan Fund”.  In the 1st quarter, our fund underwent steady growth of plus 16% (3 months, YoY), thanks to a drastic growth of Square Inc. within the 1st quarter, which was up to 117% growth.Continue reading “Watanabe & Brothers’ Investment announced the 1st Quarter Earning Results on August 16th, 2020”